近岸蛋白：2025年上半年净亏损2422.36万元

Group 1 - The company reported a revenue of 72.09 million yuan for the first half of 2025, representing a year-on-year growth of 20.85% [1] - The net loss attributable to shareholders was 24.22 million yuan, compared to a net loss of 8.91 million yuan in the same period last year [1] - The net cash flow from operating activities was -14.08 million yuan, while it was 23.30 million yuan in the same period last year [1]